HPV-Associated Oropharyngeal Cancer Rates by State
In the following maps, the states are divided into groups based on the rates at which people were diagnosed with an HPV-associated oropharyngeal cancer during 2009–2013. The rates are the average numbers out of 100,000 people who developed cancer each year.*
*Note: This study used cancer registry data to estimate the amount of HPV-associated cancer in the United States by examining cancer in parts of the body and cancer cell types that are more likely to be caused by HPV. Cancer registries do not collect data on the presence or absence of HPV in cancer tissue at the time of diagnosis. In general, HPV is thought to be responsible for about 91% of cervical cancers, 75% of vaginal cancers, 69% of vulvar cancers, 63% of penile cancers, 91% of anal cancers, and 70% of oropharyngeal cancers.
Rates are per 100,000 and age-adjusted to the 2000 U.S. Standard Population (19 age groups — Census P25-1130) standard.
Data are from population-based cancer registries participating in CDC’s National Program of Cancer Registries or the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program, include all states meeting United States Cancer Statistics publication criteria for all years 2009–2013, and cover about 99% of the U.S. population.
HPV-associated cancers were defined as cancers at specific anatomic sites with specific cellular types in which HPV DNA frequently is found. All cancers were confirmed histologically. Oropharyngeal (ICD-O-3 site codes C01.9, C02.4, C02.8, C05.1, C05.2, C09.0, C09.1, C09.8, C09.9, C10.0, C10.1, C10.2, C10.3, C10.4, C10.8, C10.9, C14.0, C14.2 and C14.8) cancers were limited to squamous cell carcinomas (ICD-O-3 histology codes 8050–8084, 8120–8131).
‡Rates were suppressed if the data did not meet USCS publication criteria or if there were fewer than 16 cases.
Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M, Centers for Disease Control and Prevention (CDC). Human papillomavirus–associated cancers—United States, 2008–2012. MMWR 2016;65(26):661–666.